2-Phenylacetamide
|
Basic information |
| Metabolite name | 2-Phenylacetamide |
 | HMDB0010715 |
 |
C02505 |
 |
7680 |
| Synonyms | Phenylacetamide |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | 2-Phenylacetamide |
| HMDB0010715 |
|
C02505 |
|
7680 |
| Synonyms | Phenylacetamide |
| No. of studies | 5 |
|
Relationship between 2-Phenylacetamide and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M131 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M209 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M454 | Type1 | vascular depression model group vs. control group | Hippocampus | ICR mouse | Down |
| Study M454 | Type2 | vascular depression model + YXST group vs. vascular depression model group | Hippocampus | ICR mouse | Up |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + Gleditsiae spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M847 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Up |